Successful establishment of a left ventricular assist device program in an emerging country: one year experience
Author(s) -
Emilija Nestorović,
Jan D. Schmitto,
Sudhir S. Kushwaha,
Svetozar Putnik,
Duško Terzić,
Nataša Milić,
Aleksandar Mikić,
Dejan Marković,
Danijela Trifunović,
Arsen Ristić,
Miljko Ristić
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.04.147
Subject(s) - medicine , ejection fraction , ventricular assist device , adverse effect , ventricle , heart failure , renal function , cardiology , blood urea nitrogen , survival rate , surgery
The primary goal of this study was to evaluate the outcomes of patients with end-stage heart failure (HF) who underwent continuous flow left ventricular assist device (CF-LVAD) in a developing country and to compare to those reported by more developed countries. The secondary goal was on determining factors that may be connected to improved survival.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom